You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plaque Psoriasis

Showing 26 - 50 of 3,338
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Compare Effectiveness of Deucravacitinib Vs Apremilast in Plaque

Recruiting
  • Psoriasis
    • Waltham, Massachusetts
      Local Institution
    Feb 15, 2023

    Psoriasis Trial in Lahore (Apremilast 30mg)

    Completed
    • Psoriasis
    • Apremilast 30mg
    • Lahore, Punjab, Pakistan
      Ghurki Hospital
    Sep 5, 2023

    Psoriasis Trial (VTAMA (tapinarof) cream, 1%)

    Not yet recruiting
    • Psoriasis
    • VTAMA (tapinarof) cream, 1%
    • (no location specified)
    Mar 16, 2023

    Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

    Recruiting
    • Plaque Psoriasis
    • Rolling Meadows, Illinois
    • +6 more
    Oct 18, 2023

    Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

    Recruiting
    • Plaque Psoriasis
    • Rolling Meadows, Illinois
    • +8 more
    Oct 18, 2023

    Plaque Psoriasis Trial in Outram Park (secukinumab, Methotrexate, Cyclosporin A)

    Not yet recruiting
    • Plaque Psoriasis
    • secukinumab
    • +3 more
    • Outram Park, Singapore
      Singapore General Hospital
    Nov 23, 2022

    Plaque Psoriasis Trial in Outram Park (Ixekizumab, Methotrexate, Cyclosporin A)

    Recruiting
    • Plaque Psoriasis
    • Ixekizumab
    • +3 more
    • Outram Park, Singapore
      Singapore General Hospital
    Nov 23, 2022

    Plaque Psoriasis Trial (apremilast, Placebo)

    Not yet recruiting
    • Plaque Psoriasis
    • (no location specified)
    Nov 3, 2023

    Effectiveness, and Safety ofFixed-dose Combination of

    Not yet recruiting
    • Plaque Psoriasis
    • CAL/BDP PAD Cream
    • (no location specified)
    Mar 31, 2023

    Plaque Psoriasis Trial (BAT2306, EU-approved Cosentyx)

    Recruiting
    • Plaque Psoriasis
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital of Zhejiang University School of
    Jan 9, 2023

    Effects, Drug Side Trial in Shanghai (Placebo, SYHX1901)

    Recruiting
    • Effects, Drug Side
    • Shanghai, Shanghai, China
      Huashan Hospital Affiliated to Fudan University
    May 4, 2023

    Apremilast in Chinese Moderate to Severe Plaque Psoriasis,Multi

    Not yet recruiting
    • Psoriasis
    • Beijing, China
    • +1 more
    May 9, 2023

    Psoriasis Trial in Lahore (Remsima)

    Completed
    • Psoriasis
    • Lahore, Punjab, Pakistan
      Ghurki Hospital
    Sep 12, 2023

    Plaque Psoriasis Trial in Fort Gratiot (Clobex Spray)

    Completed
    Has Results
    • Plaque Psoriasis
    • Clobex Spray
    • Fort Gratiot, Michigan
      Hamzavi Dermatology
    Sep 7, 2022

    Moderate-to-Severe Plaque Psoriasis Trial in Shenyang (Jaktinib, Placebo)

    Recruiting
    • Moderate-to-Severe Plaque Psoriasis
    • Shenyang, Liaoning, China
      The First Affiliated Hospital of China Medical University
    Nov 28, 2022

    Psoriasis Trial (BI 765250, Placebo)

    Not yet recruiting
    • Psoriasis
    • BI 765250
    • Placebo
    • (no location specified)
    Feb 6, 2023

    Psoriasis Trial in Shanghai (IBI112, /IBI112)

    Not yet recruiting
    • Psoriasis
    • Shanghai, Shanghai, China
      Shanghai Skin Disease Hospital
    Dec 1, 2022

    Plaque Psoriasis Trial in China (Jiuweihuaban Pill , low dose Jiuweihuaban Pill, high dose Jiuweihuaban Pill)

    Not yet recruiting
    • Plaque Psoriasis
    • Jiuweihuaban Pill placebo
    • +2 more
    • Beijing, China
    • +11 more
    Sep 27, 2023

    Psoriasis Trial in Shanghai (LZM012, Secukinumab)

    Recruiting
    • Psoriasis
    • LZM012
    • Secukinumab
    • Shanghai, Shanghai, China
      Huashan Hospital
    Oct 29, 2023

    PASI Scoring Using Digital-Based Images

    Not yet recruiting
    • Plaque Psoriasis
    • In-Person and Remote Disease Assessment
    • (no location specified)
    Apr 18, 2023

    Psoriasis Trial in Beijing (IBI112 dose 2, IBI112 dose 4, IBI112 dose 1)

    Active, not recruiting
    • Psoriasis
    • IBI112 dose 2
    • +4 more
    • Beijing, Beijing, China
      PeKing University People's Hostpital
    Jan 20, 2023

    Moderate to Severe Chronic Plaque Psoriasis Trial (CT-P17, EU-approved Humira)

    Not yet recruiting
    • Moderate to Severe Chronic Plaque Psoriasis
    • CT-P17
    • EU-approved Humira
    • (no location specified)
    Aug 8, 2022

    Secukinumab in Pediatric Plaque Psoriasis China

    Recruiting
    • Moderate to Severe Chronic Plaque Psoriasis
    • Cosentyx
    • Guangdong, Guangzhou, China
    • +7 more
    Dec 20, 2022

    Healthcare Resource Utilization Among Adult Moderate-To-Severe

    Not yet recruiting
    • Psoriasis
      • Nanjing, Jiangsu, China
        Local Institution
      Sep 16, 2022

      Plaque Psoriasis Trial in Budapest, Hévíz (balneotherapy)

      Recruiting
      • Plaque Psoriasis
      • balneotherapy
      • Budapest, Hungary
      • +1 more
      Jun 22, 2022